Pain Disorder
Pain disorder is chronic pain experienced by a patient in one or more areas, and is thought to be caused by psychological stress. The pain is often so severe that it disables the patient from proper functioning.
Cluster Number:
Wiki Number: PW149
Diagnosis: Pain Disorder
US Patients:
World Patients:
Sex Ratio: M;F+
Age Onset: Children
Brain Area:
Symptoms: Chronic pain thought to be caused by psychological stress; after accident, during illness, after drug withdrawal – but pain continues
Progression: After the pain should be gone, it increases due to attention or benefits for it.
Causes:
Medications: transcutaneous electrical nerve stimulation, trigger-point injections, surgical ablations
Therapies: CBT-talk to retrain behaviors. Lohr’s “Calming My Pain!” DVD or Download (offered on this website) may help if used as requested.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- What does low psychological distress mean in patients with no mental disorders and different pains of the musculoskeletal system?by Michael Brinkers on October 16, 2021
CONCLUSIONS: Patients without mental disorder but with chronic pain of the locomotoric system receive a psychological pain management program, as it is part of the billing code OPS 8-977 to the health insurance companies in Germany. However, the data show that these patients also have a substantial somatic subscore and a cumulative ISS above the level of healthy individuals. The absence of psychological disorders (according to ICD-10) in patients with pain of the musculoskeletal system should...
- Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwanby Szu-Min Hsieh on October 16, 2021
BACKGROUND: MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown to be well tolerated with a good safety profile in healthy adults aged 20-49 years in a phase 1 trial, and provided a good cellular and humoral immune responses. We present the interim safety, tolerability, and immunogenicity results of a phase 2 clinical trial of the MVC-COV1901 vaccine in Taiwan.
- Brain changes associated with impaired attention function in chronic painby Atsuo Yoshino on October 16, 2021
Attention function is thought to be important in chronic pain, with the pathology of chronic pain closely associated with cognitive-emotional components. However, there have been few neuroimaging studies of the relationship between attention function and chronic pain. We used the method of functional connectivity analysis for resting-state fMRI (rs-fMRI) data and the Attention Network Test-Revision (ANT-R) to clarify the attention-related pathology of chronic pain. We performed rs-fMRI and ANT-R...
- Spontaneous compartment syndrome of the forearm - case reportby K Edelmann on October 15, 2021
CONCLUSION: Spontaneous compartment syndrome of the upper extremity is a rare but very dangerous entity requiring thorough understanding. It should be considered in the case of non-traumatic limb pain that does not respond to analgesics in patients receiving systemic anticoagulation. Only early diagnosis and immediate fasciotomy can prevent catastrophic permanent consequences.